131 related articles for article (PubMed ID: 11086273)
1. [Pleconaril, a new aniviral drug with activity against picornavirus].
Reina J; Ballesteros F
Rev Esp Quimioter; 2000 Sep; 13(3):257-62. PubMed ID: 11086273
[No Abstract] [Full Text] [Related]
2. Pleconaril Sanofi Synthélabo/ViroPharma.
Billich A
Curr Opin Investig Drugs; 2000 Nov; 1(3):303-7. PubMed ID: 11249712
[TBL] [Abstract][Full Text] [Related]
3. Selective inhibitors of picornavirus replication.
De Palma AM; Vliegen I; De Clercq E; Neyts J
Med Res Rev; 2008 Nov; 28(6):823-84. PubMed ID: 18381747
[TBL] [Abstract][Full Text] [Related]
4. Pleconaril. A broad spectrum antipicornaviral agent.
Rogers JM; Diana GD; McKinlay MA
Adv Exp Med Biol; 1999; 458():69-76. PubMed ID: 10549380
[No Abstract] [Full Text] [Related]
5. Safety and efficacy evaluation of pleconaril for treatment of the common cold.
Fleischer R; Laessig K
Clin Infect Dis; 2003 Dec; 37(12):1722. PubMed ID: 14689362
[No Abstract] [Full Text] [Related]
6. The need for treatment against human parechoviruses: how, why and when?
Wildenbeest JG; Harvala H; Pajkrt D; Wolthers KC
Expert Rev Anti Infect Ther; 2010 Dec; 8(12):1417-29. PubMed ID: 21133666
[TBL] [Abstract][Full Text] [Related]
7. Oral pleconaril treatment of picornavirus-associated viral respiratory illness in adults: efficacy and tolerability in phase II clinical trials.
Hayden FG; Coats T; Kim K; Hassman HA; Blatter MM; Zhang B; Liu S
Antivir Ther; 2002 Mar; 7(1):53-65. PubMed ID: 12008788
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of oral pleconaril for treatment of colds due to picornaviruses in adults: results of 2 double-blind, randomized, placebo-controlled trials.
Hayden FG; Herrington DT; Coats TL; Kim K; Cooper EC; Villano SA; Liu S; Hudson S; Pevear DC; Collett M; McKinlay M;
Clin Infect Dis; 2003 Jun; 36(12):1523-32. PubMed ID: 12802751
[TBL] [Abstract][Full Text] [Related]
9. Pleconaril-resistant chronic parechovirus-associated enteropathy in agammaglobulinaemia.
van de Ven AA; Douma JW; Rademaker C; van Loon AM; Wensing AM; Boelens JJ; Sanders EA; van Montfrans JM
Antivir Ther; 2011; 16(4):611-4. PubMed ID: 21685550
[TBL] [Abstract][Full Text] [Related]
10. New pleconaril and [(biphenyloxy)propyl]isoxazole derivatives with substitutions in the central ring exhibit antiviral activity against pleconaril-resistant coxsackievirus B3.
Schmidtke M; Wutzler P; Zieger R; Riabova OB; Makarov VA
Antiviral Res; 2009 Jan; 81(1):56-63. PubMed ID: 18840470
[TBL] [Abstract][Full Text] [Related]
11. Inhibitors of picornavirus uncoating as antiviral agents.
Diana GD; Otto MJ; McKinlay MA
Pharmacol Ther; 1985; 29(3):287-97. PubMed ID: 3014575
[No Abstract] [Full Text] [Related]
12. [Polio-like myelitis due to Coxsackie-Virus B 3: Course under treatment with pleconaril].
Utzig N; Friedrich B; Burtzlaff C; Lauffer H
Klin Padiatr; 2003; 215(5):286-7. PubMed ID: 14520593
[TBL] [Abstract][Full Text] [Related]
13. Antiviral agents against picornaviruses.
Eggers HJ
Antiviral Res; 1985; Suppl 1():57-65. PubMed ID: 3002267
[No Abstract] [Full Text] [Related]
14. Discovery and development of antipicornaviral agents.
McKinlay MA
Scand J Infect Dis Suppl; 1993; 88():109-15. PubMed ID: 8516662
[TBL] [Abstract][Full Text] [Related]
15. Antiviral treatments reduce severity of diabetes in Ljungan virus-infected CD-1 mice and delay onset in diabetes-prone BB rats.
Holmberg R; Klitz W; Blixt M; Berggren PO; Juntti-Berggren L; Niklasson B
Microbiol Immunol; 2009 Oct; 53(10):567-72. PubMed ID: 19780970
[TBL] [Abstract][Full Text] [Related]
16. Pleconaril, a novel antipicornaviral agent.
Florea NR; Maglio D; Nicolau DP
Pharmacotherapy; 2003 Mar; 23(3):339-48. PubMed ID: 12627933
[TBL] [Abstract][Full Text] [Related]
17. Susceptibility of coxsackievirus B3 laboratory strains and clinical isolates to the capsid function inhibitor pleconaril: antiviral studies with virus chimeras demonstrate the crucial role of amino acid 1092 in treatment.
Schmidtke M; Hammerschmidt E; Schüler S; Zell R; Birch-Hirschfeld E; Makarov VA; Riabova OB; Wutzler P
J Antimicrob Chemother; 2005 Oct; 56(4):648-56. PubMed ID: 16150864
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in the treatment of rhinovirus infections.
McKinlay MA
Curr Opin Pharmacol; 2001 Oct; 1(5):477-81. PubMed ID: 11764773
[TBL] [Abstract][Full Text] [Related]
19. Picornavirus inhibitors.
Carrasco L
Pharmacol Ther; 1994; 64(2):215-90. PubMed ID: 7533301
[TBL] [Abstract][Full Text] [Related]
20. Insights into the genetic basis for natural phenotypic resistance of human rhinoviruses to pleconaril.
Ledford RM; Collett MS; Pevear DC
Antiviral Res; 2005 Dec; 68(3):135-8. PubMed ID: 16199099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
